63 related articles for article (PubMed ID: 10182556)
1. Inappropriate antibiotic therapy in febrile cancer patients with bacteremia.
Spanik S; West D; Pichna P; Novotny J; Dacok J; Mraz M; Chmelik B; Krupova I; Krcmery V
Clin Perform Qual Health Care; 1998; 6(3):109-13. PubMed ID: 10182556
[TBL] [Abstract][Full Text] [Related]
2. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
Deal EN; Micek ST; Reichley RM; Ritchie DJ
Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
[TBL] [Abstract][Full Text] [Related]
3. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
[TBL] [Abstract][Full Text] [Related]
4. Cervical cancer practice patterns and appropriateness of therapy.
Howell E; Chen YT; Moradi M; Concato J
Am J Obstet Gynecol; 2000 Aug; 183(2):407-13. PubMed ID: 10942478
[TBL] [Abstract][Full Text] [Related]
5. Central venous catheter and Stenotrophomonas maltophilia bacteremia in cancer patients.
Boktour M; Hanna H; Ansari S; Bahna B; Hachem R; Tarrand J; Rolston K; Safdar A; Raad I
Cancer; 2006 May; 106(9):1967-73. PubMed ID: 16565968
[TBL] [Abstract][Full Text] [Related]
6. [C-reactive protein concentrations during initial (empiric) treatment of neonatal sepsis].
Janković B; Pasić S; Marković M; Veljković D; Milicić M
Srp Arh Celok Lek; 2001; 129 Suppl 1():17-22. PubMed ID: 15637985
[TBL] [Abstract][Full Text] [Related]
7. Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy.
Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
Antimicrob Agents Chemother; 2004 Dec; 48(12):4574-81. PubMed ID: 15561828
[TBL] [Abstract][Full Text] [Related]
8. Bacteremia in febrile nonneutropenic pediatric oncology patients.
Kelly MJ; Vivier PM; Panken TM; Schwartz CL
Pediatr Blood Cancer; 2010 Jan; 54(1):83-7. PubMed ID: 19774640
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics and therapeutic outcome of patients with febrile neutropenia who present in shock: need for better strategies.
Malik I; Hussain M; Yousuf H
J Infect; 2001 Feb; 42(2):120-5. PubMed ID: 11531318
[TBL] [Abstract][Full Text] [Related]
10. Inappropriate antibiotic use in soft tissue infections.
Paydar KZ; Hansen SL; Charlebois ED; Harris HW; Young DM
Arch Surg; 2006 Sep; 141(9):850-4; discussion 855-6. PubMed ID: 16983028
[TBL] [Abstract][Full Text] [Related]
11. Impact of inappropriate empirical antibiotic therapy on outcome of bacteremic adults visiting the ED.
Lee CC; Lee CH; Chuang MC; Hong MY; Hsu HC; Ko WC
Am J Emerg Med; 2012 Oct; 30(8):1447-56. PubMed ID: 22205015
[TBL] [Abstract][Full Text] [Related]
12. Vancomycin-resistant enterococci bacteremia: risk factors for mortality and influence of antimicrobial therapy on clinical outcome.
Han SH; Chin BS; Lee HS; Jeong SJ; Choi HK; Kim CO; Yong D; Choi JY; Song YG; Lee K; Kim JM
J Infect; 2009 Mar; 58(3):182-90. PubMed ID: 19233476
[TBL] [Abstract][Full Text] [Related]
13. A European Organization for Research and Treatment of Cancer-International Antimicrobial Therapy Group Study of secondary infections in febrile, neutropenic patients with cancer.
Akova M; Paesmans M; Calandra T; Viscoli C;
Clin Infect Dis; 2005 Jan; 40(2):239-45. PubMed ID: 15655741
[TBL] [Abstract][Full Text] [Related]
14. Comparison of mortality of patients with Acinetobacter baumannii bacteraemia receiving appropriate and inappropriate empirical therapy.
Falagas ME; Kasiakou SK; Rafailidis PI; Zouglakis G; Morfou P
J Antimicrob Chemother; 2006 Jun; 57(6):1251-4. PubMed ID: 16627593
[TBL] [Abstract][Full Text] [Related]
15. Serratia marcescens bacteremia at a medical center in southern Taiwan: high prevalence of cefotaxime resistance.
Shih HI; Lee HC; Lee NY; Chang CM; Wu CJ; Wang LR; Ko NY; Ko WC
J Microbiol Immunol Infect; 2005 Oct; 38(5):350-7. PubMed ID: 16211144
[TBL] [Abstract][Full Text] [Related]
16. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome.
Du B; Long Y; Liu H; Chen D; Liu D; Xu Y; Xie X
Intensive Care Med; 2002 Dec; 28(12):1718-23. PubMed ID: 12447513
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the effect on patient outcomes of appropriate and inappropriate use of beta-blockers as secondary prevention after myocardial infarction in a medicaid population.
Fernandes AW; Madhavan SS; Amonkar MM
Clin Ther; 2005 May; 27(5):630-45. PubMed ID: 15978313
[TBL] [Abstract][Full Text] [Related]
18. An interventional controlled trial comparing 2 management models for the treatment of tunneled cuffed catheter bacteremia: a collaborative team model versus usual physician-managed care.
Mokrzycki MH; Zhang M; Golestaneh L; Laut J; Rosenberg SO
Am J Kidney Dis; 2006 Oct; 48(4):587-95. PubMed ID: 16997055
[TBL] [Abstract][Full Text] [Related]
19. Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: impact of delayed appropriate antibiotic selection.
Lodise TP; Patel N; Kwa A; Graves J; Furuno JP; Graffunder E; Lomaestro B; McGregor JC
Antimicrob Agents Chemother; 2007 Oct; 51(10):3510-5. PubMed ID: 17646415
[TBL] [Abstract][Full Text] [Related]
20. Daptomycin therapy for vancomycin-resistant enterococcal bacteremia: a retrospective case series of 30 patients.
Gallagher JC; Perez ME; Marino EA; LoCastro LG; Abrardo LA; MacDougall C
Pharmacotherapy; 2009 Jul; 29(7):792-9. PubMed ID: 19558253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
